Clinical Trials Directory

Trials / Unknown

UnknownNCT01286597

The Effects of Lactose Intolerance on Gastrointestinal Function and Symptoms in a Chinese Population

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
3,000 (estimated)
Sponsor
Sir Run Run Shaw Hospital · Academic / Other
Sex
All
Age
16 Years – 75 Years
Healthy volunteers
Accepted

Summary

Lactose is a carbohydrate found in milk,and Lactase Deficiency (LD) is a condition in which the small intestine cannot digest this carbohydrate due to absent or insufficient amounts of lactase.Individuals with LD may be intolerant of lactose in the diet and experience abdominal cramps, bloating and diarrhea; however the response is variable.Some tolerate moderate amounts of lactose without adverse effect,whereas others experience severe symptoms in response to even small doses. These problems may be representative of wider issues regarding individual tolerance to diet containing ubiquitous poorly absorbed, fermentable carbohydrates (such as: fructose, fructans)and be relevant to symptom generated in patients with diarrhea predominant irritable bowel syndrome (D-IBS). This project will investigate the effects of diet,lifestyle stress and psychiatric dietary on the development of functional gastrointestinal symptoms. Lactose will be used to assess tolerance to dietary challenge, a test that is particularly relevant in a Chinese population with a high prevalence of lactase deficiency.

Detailed description

Study #1: Questionnaire study in general Chinese population (n=2000). Study #2: Physiologic study in patients attending gastroenterology clinic (n=600) including in subgroups assessment of genetic factors,tolerance to lactose challenge and assessment of visceral sensitivity. Study #3: Assessment of appropriate dosage of lactose hydrogen breath test in a population with high-prevalence of lactase deficiency. Study #4: Impact of a determined dietary intervention on abdominal symptoms compatible with D-IBS. study #5: The association of visceral sensitivity induced by LI with mucosal immune activation and psychological factors in D-IBS patients

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTdietary restrictionrestrict intake of lactose

Timeline

Start date
2011-01-01
Primary completion
2012-12-01
Completion
2012-12-01
First posted
2011-01-31
Last updated
2012-07-10

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01286597. Inclusion in this directory is not an endorsement.